Skip to content
T33T33T33

Drawing based on the label description. No photo yet.

“Irbesartan Tablets USP, 300 mg are white to off-white, biconvex, oval shaped uncoated tablets debossed with 'T33' on one side and plain on other side”

T33 pill

Pill with imprint T33 is white, oval, 17 mm and has been identified as Irbesartan 300 mg. It is used for high blood pressure, a weak heart and kidney disease from diabetes. It is supplied by Aurobindo Pharma Limited.

Irbesartan 300 mg

Imprint
T33
Strength
300 mg
Used for
High blood pressure, a weak heart and kidney disease from diabetes
Color
White
Shape
Oval
Size
17 mm
Score
No score line
Form
Tablet
Manufacturer
Aurobindo Pharma Limited
Drug class
ARB (blood pressure medicine)
NDC
65862-639, 65862-639-30, 65862-639-90, 65862-639-05, 65862-639-10, 65862-639-78

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Irbesartan pills and guides

What is Irbesartan used for?

Irbesartan is used for high blood pressure, a weak heart and kidney disease from diabetes.

Medicine type
ARB (blood pressure medicine)
Official uses from the US prescribing label

Hypertension

Irbesartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Irbesartan tablets may be used alone or in combination with other antihypertensive agents.

Nephropathy in Type 2 Diabetic Patients

Irbesartan tablets are indicated for the treatment of diabetic nephropathy in patients with type 2 diabetes and hypertension, an elevated serum creatinine, and proteinuria (>300 mg/day). In this population, irbesartan tablets reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end-stage renal disease (need for dialysis or renal transplantation).

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows T33 and the other side is plain.
  • It is white, oval, 17 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Irbesartan

Inactive: Silicon Dioxide, Dibasic Calcium Phosphate Dihydrate, Hypromellose 2910 (5 Mpa.s), Microcrystalline Cellulose, Polysorbate 80, Sodium Starch Glycolate Type A Potato, Sodium Stearyl Fumarate, Talc

Other pills with imprint T 33

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Irbesartan pills